Advanced cardiovascular screening is more important today than it’s ever been. Undetected cardiovascular disease is the greatest health risk facing people today. Heart disease remains the leading cause of death for both men and women as about 600,000 people die of heart disease in the United States every year–that’s 1 in every 4 deaths. Unfortunately, most of these deaths were preventable had there been a comprehensive evaluation and appropriate guidance and care.
Standard cholesterol tests do not tell the whole picture in gauging an individual’s risk of cardiovascular disease. Increasingly, general medical consensus views the standard cholesterol testing as only a part of the information needed for an accurate assessment of imminent and ongoing risk and believe chronic silent inflammation plays a more critical role in the development of heart disease.
At The Lamkin Clinic, we have developed a unique, comprehensive risk-assessment protocol, including diagnostics and lab work aimed at early detection of underlying metabolic, genetic, and other silent risk biomarkers for cardiovascular disease.
Your Advanced Cardiovascular Screening may include one or more of the following:
A basic and traditional group of tests used to determine risk for cardiovascular and related diseases. This is a good start, but we recommend combining with more advanced testing for a more accurate picture of health.
This information is a much better predictor of risk than traditional lipid profiles alone. This can give us a more in-depth look at your heart health and better determine your risk for developing disease.
This unique test analyzes the omega constituents of red blood cells providing a longer-term indicator of adequate consumption and or supplementation again affecting treatment guidelines.
Bio-markers of insulin sensitivity and blood sugar control are important indicators that can lead to early detection of diabetes, which increases the risk of heart disease.
Our Health Diagnostic Laboratory offers comprehensive panels of advanced tests that include nutritional markers that can help illustrate the underlying cause of vessel inflammation.
This is a non-invasive procedure using computed tomography to measure the number of calcium deposits in the heart, especially deposits in the coronary arteries.
Advanced tests detect strain or other damage to the heart muscle, which can lead to more appropriate treatment for preventing heart attacks. This can help determine if a referral for echocardiogram and specialty cardiology consultation is necessary.
Genetic markers not only help predict risk for heart attacks and strokes but help guide treatment. Several markers help determine the genetic propensity of an individual to form plaque in their arteries develop clots, which lead to heart attacks and strokes.
The Ankle Brachial Index (ABI) is the ratio of the blood pressure in the lower legs to the blood pressure in the arms. Compared to the arm, lower blood pressure in the leg is an indication of blocked arteries (peripheral vascular disease or PVD).
A non-invasive, state-of-the-art, cost-effective diagnostic tool for the earliest detection of cardiovascular disease. The value of carotid IMT (Intima-Media Thickness) has been recognized by the American Heart Association (and others) for the early detection of heart disease. This technology won “Most Life-Changing Product” at the 2008 BIOCOM conference.
The modified “tilt” test simply measures blood pressure and heart rate while laying down, sitting up, and standing. The tilt test is a test used to evaluate and diagnose a condition called neurocardiogenic syncope, which is a common cause of lightheaded spells or fainting or passing out which can occur in otherwise healthy individuals.
Body composition measurement with dual-energy X-ray absorptiometry (DEXA)* can look beyond weight and the traditional body mass index (BMI) to determine body fat distribution, lean muscle mass, and body fat percentage. Body composition measurement contributes to thorough patient evaluation and helps our physician fully assess an individual’s risk of cardiovascular disease.
The MetaCheck from Korr Medical Technologies measures a person’s resting metabolic rate with a simple 10- minute breath test. The technology once reserved for hospitals and universities is now available at The Lamkin Clinic.
A monitored stress EKG and pulmonary function will be performed by a technician and under the supervision of Dr. Lamkin.
Dr. Lamkin will schedule a one-hour face-to-face consultation with you to review all of your diagnostic and lab results from the advanced cardiovascular screening. This will be an essential starting point in the exploration of your health. Dr. Lamkin believes that the vast majority of heart disease is preventable. Once your unique metabolic, genetic, and inflammatory markers are identified, you will feel empowered knowing where your risk lies and better be able to address those areas of concern. This assessment may be part of a more extensive evaluation depending on your unique circumstances and health goals.